Literature DB >> 2654351

An evaluation of the possible neurotoxicity of metabolites of phenylalanine.

S Kaufman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2654351     DOI： 10.1016/s0022-3476(89)80161-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  13 in total

1.  A synopsis of the unconjugated acidic transamination metabolites of phenylalanine in phenylketonuria.

Authors:  U Langenbeck; A Behbehani; A Mench-Hoinowski
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 2.  Garrod's foresight; our hindsight.

Authors:  C R Scriver
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

3.  In vivo disposal of phenylalanine in phenylketonuria: a study of two siblings.

Authors:  E Treacy; J J Pitt; K Seller; G N Thompson; S Ramus; R G Cotton
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Examination of urine metabolites in the newborn period and during protein loading tests at 6 months of age--Part 1.

Authors:  E Mönch; J Kneer; C Jakobs; M Arnold; H Diehl; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

5.  Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites.

Authors:  Renaud Schoemans; Marie-Stéphane Aigrot; Chaohong Wu; Raphaël Marée; Pengyu Hong; Shibeshi Belachew; Claire Josse; Catherine Lubetzki; Vincent Bours
Journal:  J Inherit Metab Dis       Date:  2010-02-12       Impact factor: 4.982

6.  Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.

Authors:  Bert K Lopansri; Nicholas M Anstey; Gregory J Stoddard; Esther D Mwaikambo; Craig S Boutlis; Emiliana Tjitra; Helena Maniboey; Maurine R Hobbs; Marc C Levesque; J Brice Weinberg; Donald L Granger
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 7.  Phenylketonuria: Current Treatments and Future Developments.

Authors:  Uta Lichter-Konecki; Jerry Vockley
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

8.  Biochemical, Metabolic, and Behavioral Characteristics of Immature Chronic Hyperphenylalanemic Rats.

Authors:  Gerald A Dienel; Nancy F Cruz
Journal:  Neurochem Res       Date:  2015-07-30       Impact factor: 3.996

Review 9.  Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria.

Authors: 
Journal:  BMJ       Date:  1993-01-09

10.  L-carnitine protects DNA oxidative damage induced by phenylalanine and its keto acid derivatives in neural cells: a possible pathomechanism and adjuvant therapy for brain injury in phenylketonuria.

Authors:  Jéssica Lamberty Faverzani; Aline Steinmetz; Marion Deon; Desirèe Padilha Marchetti; Gilian Guerreiro; Angela Sitta; Daniella de Moura Coelho; Franciele Fatima Lopes; Leopoldo Vinicius Martins Nascimento; Luiza Steffens; Jeferson Gustavo Henn; Matheus Bernardes Ferro; Verônica Bidinotto Brito; Moacir Wajner; Dinara Jaqueline Moura; Carmen Regla Vargas
Journal:  Metab Brain Dis       Date:  2021-07-03       Impact factor: 3.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.